Exact Mass: 845.4690181999999
Exact Mass Matches: 845.4690181999999
Found 17 metabolites which its exact mass value is equals to given mass value 845.4690181999999
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Thrombin receptor peptide sfllrnp
C39H63N11O10 (845.4759138000001)
(2s)-n-[(3s,6s,9s,12r,13s,16r,21as)-16-benzyl-1,4,7,14-tetrahydroxy-3,6,9-triisopropyl-12-methyl-10,17-dioxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-l]1-oxa-4,7,10,13,16-pentaazacyclononadecan-13-yl]-2-[(1-hydroxy-2-phenylethylidene)amino]butanimidic acid
C45H63N7O9 (845.4687028000001)
(2r,3s)-2-{[(2r)-4-{[(2r,3s)-2-amino-1,3-dihydroxybutylidene]amino}-2-{[(2r)-1,3-dihydroxy-2-{[(2r)-1-hydroxy-5-(c-hydroxycarbonimidoylamino)-2-{[(2e)-1-hydroxydec-2-en-1-ylidene]amino}pentylidene]amino}propylidene]amino}-1-hydroxybutylidene]amino}-3-hydroxy-n-[(2r)-1-hydroxy-3-(c-hydroxycarbonimidoyl)propan-2-yl]butanediimidic acid
(2s)-n-[(3s,6s,9s,12r,13s,16r,21as)-16-benzyl-6-ethyl-1,4,7,14-tetrahydroxy-3,9-diisopropyl-12-methyl-10,17-dioxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-l]1-oxa-4,7,10,13,16-pentaazacyclononadecan-13-yl]-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutanimidic acid
C45H63N7O9 (845.4687028000001)
n-{16-benzyl-6-ethyl-1,4,7,14-tetrahydroxy-3,9-diisopropyl-12-methyl-10,17-dioxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-l]1-oxa-4,7,10,13,16-pentaazacyclononadecan-13-yl}-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutanimidic acid
C45H63N7O9 (845.4687028000001)
(2s,3r)-2-{[(2r)-4-{[(2r,3r)-2-amino-1,3-dihydroxybutylidene]amino}-2-{[(2s)-1,3-dihydroxy-2-{[(2s)-1-hydroxy-5-(c-hydroxycarbonimidoylamino)-2-{[(2e)-1-hydroxydec-2-en-1-ylidene]amino}pentylidene]amino}propylidene]amino}-1-hydroxybutylidene]amino}-3-hydroxy-n-[(2s)-1-hydroxy-3-(c-hydroxycarbonimidoyl)propan-2-yl]butanediimidic acid
(2z)-n-[(1r)-1-{[(1s)-1-{[(1s,2s)-1-[(2-amino-4-{[(2s,3s)-2-amino-1,3-dihydroxybutylidene]amino}butanoyl)[(2s)-1-hydroxy-3-(c-hydroxycarbonimidoyl)propan-2-yl]carbamoyl]-2-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}-2-hydroxyethyl]-c-hydroxycarbonimidoyl}-4-(c-hydroxycarbonimidoylamino)butyl]dec-2-enimidic acid
(2r)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-benzyl-2,8-bis[(2s)-butan-2-yl]-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
n-[5-benzyl-15-(3-carbamimidamidopropyl)-6,13,16,21-tetrahydroxy-4,11-dimethyl-3,9,22-trioxo-2,8-bis(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2,3-dihydroxypropanimidic acid
n-{16-benzyl-1,4,7,14-tetrahydroxy-3,6,9-triisopropyl-12-methyl-10,17-dioxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-l]1-oxa-4,7,10,13,16-pentaazacyclononadecan-13-yl}-2-[(1-hydroxy-2-phenylethylidene)amino]butanimidic acid
C45H63N7O9 (845.4687028000001)